Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002246.SZ Stock Summary
Top 10 Correlated ETFs
002246.SZ
In the News
002246.SZ Financial details
Company Rating
Buy
Market Cap
4.14B
Income
17.04M
Revenue
2.17B
Book val./share
5.17
Cash/share
2.49
Dividend
0.05
Dividend %
0.64%
Employees
3.2K
Optionable
No
Shortable
Yes
Earnings
29 Apr 2021
P/E
247.51
Forward P/E
-
PEG
-30.62
P/S
1.98
P/B
1.49
P/C
3.1
P/FCF
-18.21
Quick Ratio
1.84
Current Ratio
2.18
Debt / Equity
0.02
LT Debt / Equity
0.02
-
-
EPS (TTM)
0.03
EPS next Y
-
EPS next Q
-
EPS this Y
-5.56%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-5.87%
Revenue last 5Y
1.6%
Revenue Q/Q
-12.45%
EPS Q/Q
-186.78%
-
-
-
-
SMA20
14.29%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
1%
ROC
-
Gross Margin
18%
Oper. Margin
1%
Profit Margin
1%
Payout
-
Shs Outstand
549.04M
Shs Float
284.55M
-
-
-
-
Target Price
-
52W Range
5.47-10.77
52W High
-22.7%
52W Low
+54.6%
RSI
58
Rel Volume
1.86
Avg Volume
5.88M
Volume
10.96M
Perf Week
1.58%
Perf Month
27.14%
Perf Quarter
-
Perf Half Y
-12.66%
-
-
-
-
Beta
0.59
-
-
Volatility
0.1%, 0.4%
Prev Close
1.05%
Price
7.73
Change
-1.02%
002246.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.4 | 4.5 | 4.3 | 4.8 | 4.68 | |
Net income per share | 0.23 | 0.25 | 0.16 | 0.18 | 0.17 | |
Operating cash flow per share | 0.25 | 0.69 | 0.77 | 0.43 | 0.2 | |
Free cash flow per share | 0.11 | 0.59 | 0.61 | 0.11 | -0.05 | |
Cash per share | 0.83 | 1.55 | 2.99 | 3.19 | 3.21 | |
Book value per share | 4.48 | 4.6 | 4.78 | 4.96 | 5.22 | |
Tangible book value per share | 4.27 | 4.4 | 4.58 | 4.72 | 4.97 | |
Share holders equity per share | 4.48 | 4.6 | 4.78 | 4.96 | 5.22 | |
Interest debt per share | 0.01 | 0.45 | 0.63 | 0.13 | 0.15 | |
Market cap | 3.47B | 4.11B | 4.02B | 5.61B | 5.23B | |
Enterprise value | 3.02B | 3.29B | 3.22B | 4.29B | 3.78B | |
P/E ratio | 28.03 | 30.08 | 44.63 | 58.29 | 56.18 | |
Price to sales ratio | 1.47 | 1.67 | 1.71 | 2.13 | 2.04 | |
POCF ratio | 25.96 | 10.84 | 9.54 | 23.92 | 47.94 | |
PFCF ratio | 59.47 | 12.85 | 11.96 | 90.73 | -187.41 | |
P/B Ratio | 1.44 | 1.63 | 1.53 | 2.06 | 1.83 | |
PTB ratio | 1.44 | 1.63 | 1.53 | 2.06 | 1.83 | |
EV to sales | 1.28 | 1.34 | 1.37 | 1.63 | 1.48 | |
Enterprise value over EBITDA | 10.76 | 11.8 | 14.83 | 15.51 | 18.33 | |
EV to operating cash flow | 22.65 | 8.69 | 7.64 | 18.3 | 34.64 | |
EV to free cash flow | 51.88 | 10.29 | 9.58 | 69.41 | -135.43 | |
Earnings yield | 0.04 | 0.03 | 0.02 | 0.02 | 0.02 | |
Free cash flow yield | 0.02 | 0.08 | 0.08 | 0.01 | -0.01 | |
Debt to equity | 0 | 0.1 | 0.13 | 0.02 | 0.03 | |
Debt to assets | 0 | 0.06 | 0.08 | 0.01 | 0.02 | |
Net debt to EBITDA | -1.57 | -2.93 | -3.68 | -4.76 | -7.03 | |
Current ratio | 2.42 | 2.33 | 2.3 | 2.13 | 2.07 | |
Interest coverage | -81.89 | 165.66 | -270.39 | 51.71 | 19.4 | |
Income quality | 1.07 | 2.81 | 5.17 | 2.44 | 1.23 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Payout ratio | 0.21 | 0.22 | 0.34 | 0.23 | 0.27 | |
Sales general and administrative to revenue | 0.02 | 0.02 | 0.04 | 0.02 | 0.02 | |
Research and developement to revenue | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | |
Intangibles to total assets | 0.09 | 0.08 | 0.08 | 0.07 | 0.07 | |
Capex to operating cash flow | -0.56 | -0.16 | -0.2 | -0.74 | -1.26 | |
Capex to revenue | -0.03 | -0.02 | -0.04 | -0.07 | -0.05 | |
Capex to depreciation | -0.83 | -0.64 | -0.89 | -1.65 | -1.32 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.81 | 5.09 | 4.2 | 4.42 | 4.47 | |
ROIC | 0.05 | 0.05 | 0.03 | 0.05 | 0.03 | |
Return on tangible assets | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | |
Graham Net | 0.58 | 0.86 | 1.94 | 1.78 | 1.9 | |
Working capital | 1.34B | 1.48B | 1.62B | 1.64B | 1.65B | |
Tangible asset value | 2.29B | 2.4B | 2.52B | 2.59B | 2.72B | |
Net current asset value | 1.29B | 1.4B | 1.5B | 1.46B | 1.51B | |
Invested capital | 0 | 0.1 | 0.13 | 0.02 | 0.03 | |
Average receivables | 774.51M | 782.85M | 724.54M | 771.83M | 912.83M | |
Average payables | 647.57M | 725.76M | 741.47M | 765.85M | 909.44M | |
Average inventory | 444.62M | 488.06M | 512.34M | 492.81M | 461.03M | |
Days sales outstanding | 129.84 | 107.53 | 112.06 | 113.59 | 143.52 | |
Days payables outstanding | 137.75 | 150.7 | 138.54 | 143.53 | 175.12 | |
Days of inventory on hand | 90.13 | 103.74 | 96.12 | 86.14 | 75.28 | |
Receivables turnover | 2.81 | 3.39 | 3.26 | 3.21 | 2.54 | |
Payables turnover | 2.65 | 2.42 | 2.63 | 2.54 | 2.08 | |
Inventory turnover | 4.05 | 3.52 | 3.8 | 4.24 | 4.85 | |
ROE | 0.05 | 0.05 | 0.03 | 0.04 | 0.03 | |
Capex per share | -0.14 | -0.11 | -0.16 | -0.31 | -0.25 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.03 | 1.27 | 0.71 | 1.12 | 0.93 | |
Net income per share | 0.04 | 0.01 | 0.02 | 0.07 | -0.06 | |
Operating cash flow per share | 0.04 | 0.01 | 0.02 | -0.08 | -0.16 | |
Free cash flow per share | 0 | -0.15 | 0 | -0.11 | -0.18 | |
Cash per share | 2.58 | 3.24 | 2.81 | 2.92 | 2.49 | |
Book value per share | 5.19 | 5.26 | 5.22 | 5.51 | 5.17 | |
Tangible book value per share | 4.94 | 5.01 | 4.98 | 5.26 | 4.93 | |
Share holders equity per share | 5.19 | 5.26 | 5.22 | 5.51 | 5.17 | |
Interest debt per share | 0.15 | 0.15 | 0.15 | 0.14 | 0.12 | |
Market cap | 5.55B | 5.18B | 5.59B | 4.92B | 4.9B | |
Enterprise value | 4.49B | 3.73B | 4.36B | 3.48B | 3.84B | |
P/E ratio | 57.43 | 229.45 | 164.52 | 35.93 | -39.1 | |
Price to sales ratio | 9.82 | 7.52 | 14.34 | 8.46 | 9.62 | |
POCF ratio | 229.7 | 917.81 | 658.06 | -120.64 | -54.13 | |
PFCF ratio | -3.99K | -61.87 | -6.89K | -88.88 | -51 | |
P/B Ratio | 1.95 | 1.81 | 1.95 | 1.72 | 1.73 | |
PTB ratio | 1.95 | 1.81 | 1.95 | 1.72 | 1.73 | |
EV to sales | 7.94 | 5.41 | 11.17 | 5.97 | 7.54 | |
Enterprise value over EBITDA | 182.89 | 1.19K | 549.03 | 74.25 | -131.43 | |
EV to operating cash flow | 185.69 | 660.88 | 512.82 | -85.18 | -42.42 | |
EV to free cash flow | -3.22K | -44.55 | -5.37K | -62.76 | -39.96 | |
Earnings yield | 0 | 0 | 0 | 0.01 | -0.01 | |
Free cash flow yield | 0 | -0.02 | 0 | -0.01 | -0.02 | |
Debt to equity | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | |
Debt to assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
Net debt to EBITDA | -43.34 | -463.11 | -155.51 | -30.9 | 36.31 | |
Current ratio | 2.14 | 2.07 | 2.16 | 2.2 | 2.18 | |
Interest coverage | 17.64 | 5.04 | 8.94 | 35.88 | -52.02 | |
Income quality | 1 | 1 | 1 | -1.19 | 2.89 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 1.02 | 4.38 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.28 | -0.19 | 0.09 | -0.01 | 0.27 | |
Research and developement to revenue | 0.05 | 0.04 | 0.04 | 0.04 | 0.05 | |
Intangibles to total assets | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | |
Capex to operating cash flow | -1.06 | -15.83 | -1.1 | 0.36 | 0.06 | |
Capex to revenue | -0.05 | -0.13 | -0.02 | -0.03 | -0.01 | |
Capex to depreciation | -0.97 | -3.4 | -0.31 | -0.49 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.27 | 1.11 | 1.35 | 2.86 | 2.58 | |
ROIC | 0.01 | 0 | 0 | 0.01 | -0.01 | |
Return on tangible assets | 0.01 | 0 | 0 | 0.01 | -0.01 | |
Graham Net | 1.82 | 1.91 | 1.84 | 1.99 | 1.82 | |
Working capital | 1.69B | 1.65B | 1.67B | 1.7B | 1.68B | |
Tangible asset value | 2.71B | 2.72B | 2.73B | 2.74B | 2.71B | |
Net current asset value | 1.57B | 1.51B | 1.53B | 1.57B | 1.56B | |
Invested capital | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | |
Average receivables | 1.16B | 1.12B | 1.03B | 1.06B | 1.16B | |
Average payables | 1.03B | 1.03B | 990.78M | 980.76M | 962.82M | |
Average inventory | 488.28M | 473.44M | 466.21M | 510.63M | 497.03M | |
Days sales outstanding | 197.94 | 131.43 | 241.76 | 165.07 | 222.09 | |
Days payables outstanding | 208.51 | 158.1 | 274.02 | 195.79 | 198.32 | |
Days of inventory on hand | 101.89 | 67.96 | 140.2 | 103.72 | 99.62 | |
Receivables turnover | 0.45 | 0.68 | 0.37 | 0.55 | 0.41 | |
Payables turnover | 0.43 | 0.57 | 0.33 | 0.46 | 0.45 | |
Inventory turnover | 0.88 | 1.32 | 0.64 | 0.87 | 0.9 | |
ROE | 0.01 | 0 | 0 | 0.01 | -0.01 | |
Capex per share | -0.05 | -0.16 | -0.02 | -0.03 | -0.01 |
002246.SZ Frequently Asked Questions
What is North Chemical Industries Co., Ltd. stock symbol ?
North Chemical Industries Co., Ltd. is a CN stock and trading under the symbol 002246.SZ
What is North Chemical Industries Co., Ltd. stock quote today ?
North Chemical Industries Co., Ltd. stock price is $7.73 today.
Is North Chemical Industries Co., Ltd. stock public?
Yes, North Chemical Industries Co., Ltd. is a publicly traded company.